See every side of every news story

Published 1 month ago • loading... • Updated 1 month ago

Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues

Summary by The Norfolk Daily News

GALWAY, Ireland and CHICAGO, April 25, 2026

16 Articles

16 Articles

The Norfolk Daily News

+14 Reposted by 14 other sources

Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues

GALWAY, Ireland and CHICAGO, April 25, 2026

1 month ago

Read Full Article

In Medtronic study, 65.5% stayed free of repeat VT at 6 months

Sphere-360 showed 100% lesion durability in a sub-analysis, while Conquer-AF enrolled its first patient for repeat-ablation cases.

1 month ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources16

Leaning Left1Leaning Right0Center7Last Updated1 month agoBias Distribution

87% Center

Bias Distribution

87% of the sources are Center

87% Center

+2

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States 1 month ago on Saturday, April 25, 2026.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics